Ross Thomas M.'s Form 4 filing
Maxcyte, Inc. (MXCT) · filed Feb 3, 2023
- Accession no.
- 0001209191-23-006880
- Filed
- Feb 3, 2023
- Trade date
- Feb 1-2, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $166.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ross Thomas M.CIK 0001874572 | Officer (EVP, Global Sales & Marketing) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | Common Stock | MOption exerciseAcquired | +2,468 | $0.98 | +$2,418.64 | 2,468 | Direct | |
| Feb 1, 2023 | Common Stock | MOption exerciseAcquired | +15,090 | $2.14 | +$32,292.6 | 17,558 | Direct | |
| Feb 1, 2023 | Common Stock | SSaleDisposed | −17,558 | $5.68 | −$99,729.44 | 0 | Direct | |
| Feb 2, 2023 | Common Stock | MOption exerciseAcquired | +11,575 | $2.14 | +$24,770.5 | 11,575 | Direct | |
| Feb 2, 2023 | Common Stock | SSaleDisposed | −11,575 | $5.77 | −$66,787.75 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | Common Stock | MOption exerciseDisposed | −2,468 | $0.00 | $0 | 0 | Direct | |
| Feb 1, 2023 | Common Stock | MOption exerciseDisposed | −15,090 | $0.00 | $0 | 83,710 | Direct | |
| Feb 2, 2023 | Common Stock | MOption exerciseDisposed | −11,575 | $0.00 | $0 | 72,135 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.